Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telmisartan vs Losartan in Renal Transplant Recipients
NCT01224860Phase 2Completed
- Sponsor
- Mario Negri Institute for Pharmacological Research
- Start
- Jan 2009
- Primary completion
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of telmisartan in metabolic syndrome (2 arms), sponsored by Mario Negri Institute for Pharmacological Research. Primary endpoint: Insulin sensitivity at 9 months. Started Jan 2009; status: completed.
02
Drugs
telmisartan
03
Conditions
metabolic syndrome
Beyond the preview
Go deeper on NCT01224860.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01224860.